The European Medicines Agency’s main scientific committee has recommended that patients with chronic hepatitis C virus infection before or after a liver transplantation be given the opportunity to be treated with the experimental drug sofosbuvir. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
